Moderna’s mFLUZIA Flu Vaccine Available in Billings for Adults 50 and Older
The first mRNA flu vaccine, Moderna's mFLUZIA, is now available in Billings for adults aged 50 and older, utilizing technology similar to the COVID-19 vaccine. While some pharmacies carry it, major health clinics in the area are still awaiting its…
Billings, MT, October 28, 2026 —
Moderna’s mFLUZIA, described as the first mRNA flu vaccine, is now available in Billings for adults aged 50 and older. The vaccine uses technology similar to that used in the COVID-19 vaccine, according to the information provided.
Access in the area is not yet uniform. Some pharmacies carry mFLUZIA, while major health clinics in Billings are still awaiting its arrival. The names of the pharmacies and clinics were not provided, and no specific arrival dates for the clinics were given.
The information available does not identify which pharmacies currently have doses or explain how people can confirm availability. It also does not provide details about the vaccine’s formulation, effectiveness, side effects, pricing, insurance coverage or how it compares with other flu vaccines. No statements from Moderna, local health providers or public health officials were included.
The reported age group for mFLUZIA in Billings is adults 50 and older. The available information does not specify whether access is subject to additional eligibility requirements or whether the vaccine is available to people outside that age group elsewhere.
For now, the key local distinction is between pharmacies that carry the vaccine and major health clinics that have not yet received it. The timing of broader availability through clinics remains unclear. The information provided does not say when those clinics expect deliveries, so no timeline for expanded local access can be confirmed.
Story summarized from the original created by Grace Stewart on www.ktvq.com, see more information here.
Media gallery
